Outcome after single cord blood unit transplantations in adult patients
Investigator . | No. patients . | Diseases . | Median follow-up time, mo . | Disease-free survival, % . |
---|---|---|---|---|
Laughlin et al41 | 68 | CML, AML, CLL, ALL, lymphoma | 22 | 26 |
Long et al42 | 57 | CML, AML, CLL, ALL, lymphoma, other | 56 | 19 |
Sanz et al43 | 22 | CML, AML, MDS, ALL | 8 | 53 |
Ooi et al44 | 18 | AML | 18 | 76 |
Laughlin et al46 | 116 | CML, AML, MDS, ALL | 40 | 23 |
Rocha et al47 | 98 | AML, ALL | 27 | 33 |
Investigator . | No. patients . | Diseases . | Median follow-up time, mo . | Disease-free survival, % . |
---|---|---|---|---|
Laughlin et al41 | 68 | CML, AML, CLL, ALL, lymphoma | 22 | 26 |
Long et al42 | 57 | CML, AML, CLL, ALL, lymphoma, other | 56 | 19 |
Sanz et al43 | 22 | CML, AML, MDS, ALL | 8 | 53 |
Ooi et al44 | 18 | AML | 18 | 76 |
Laughlin et al46 | 116 | CML, AML, MDS, ALL | 40 | 23 |
Rocha et al47 | 98 | AML, ALL | 27 | 33 |
ALL indicates acute lymphocytic leukemia; AML, acute myeloid leukemia; MDS, myelodysplastic syndrome; CML, chronic myeloid leukemia; CLL, chronic lymphocytic leukemia.